cabergoline

The medicine is used to inhibit lactation (milk production) after childbirth or to terminate it. It is also indicated for the treatment of disorders related to excessive prolactin secretion (e.g., amenorrhea, anovulation, galactorrhea) and for the treatment of pituitary adenoma or empty sella syndrome associated with high prolactin levels.

Form: tablets

ATC: G02CB03

Manufacturer: Pfizer, S.L.

The medicine is used to inhibit lactation (milk production) after childbirth or to terminate it. It is also indicated for the treatment of disorders related to excessive prolactin secretion (e.g., irregular menstruation, lack of ovulation, galactorrhea) and in the treatment of pituitary adenoma or empty sella syndrome associated with high prolactin levels.

Form: tablets

ATC: G02CB03

Manufacturer: Pfizer, S.L.

The medicine is used to suppress lactation (milk production) after childbirth or to terminate it. It is also used to treat disorders related to excessive prolactin secretion (e.g., irregular menstruation, lack of ovulation) and in the treatment of pituitary adenoma.

Form: tablets

ATC: G02CB03

Manufacturer: Pfizer Europe MA EEIG

The medicine is used to inhibit lactation (milk production) after childbirth or to interrupt it. It is also used in the treatment of disorders related to excessive prolactin secretion (e.g., irregular menstruation, lack of ovulation) and in the treatment of pituitary adenoma.

Form: tablets

ATC: G02CB03

Manufacturer: Pfizer Europe MA EEIG

The medicine is used to inhibit lactation (milk production) after childbirth or to stop it. It is also used to treat disorders related to excessive prolactin secretion (e.g., irregular periods, lack of ovulation, galactorrhea) and in the treatment of pituitary adenoma and other conditions associated with high prolactin levels.

Form: tablets

ATC: G02CB03

Manufacturer: Pfizer Europe MA EEIG

The medicine is used to inhibit lactation after childbirth or to stop milk secretion. It is also indicated for the treatment of disorders related to excessive prolactin secretion (e.g., amenorrhea, lack of ovulation, galactorrhea) and for the treatment of pituitary adenoma or empty sella syndrome associated with excess prolactin.

Form: tablets

ATC: G02CB03

Manufacturer: Pfizer, S.L.

The medicine is used to inhibit lactation (milk production) after childbirth or to discontinue it. It is also used to treat disorders related to excessive prolactin secretion (e.g., irregular menstruation, lack of ovulation) and in the treatment of pituitary adenoma.

Form: tablets

ATC: G02CB03

Manufacturer: Pfizer Europe MA EEIG

The medicine is used to suppress lactation (milk production) after childbirth or to interrupt it. It is also used to treat disorders related to excessive prolactin secretion (e.g., amenorrhea, lack of ovulation, galactorrhea) and in the treatment of pituitary adenoma or empty sella syndrome associated with high prolactin levels.

Form: tablets

ATC: G02CB03

Manufacturer: Pfizer BV

The medicine is used to inhibit lactation (milk production) after childbirth or to stop it. It is also used to treat disorders related to excessive prolactin secretion (e.g., absence of menstruation, absence of ovulation, galactorrhea) and in the treatment of pituitary adenoma.

Form: tablets

ATC: G02CB03

Manufacturer: Pfizer Europe MA EEIG

The medicine is used to suppress lactation (milk production) after childbirth or to terminate it. It is also used to treat disorders related to excessive prolactin secretion (e.g., irregular menstruation, lack of ovulation) and in the treatment of pituitary adenoma.

Form: tablets

ATC: G02CB03

Manufacturer: Pfizer BV

The medicine is used to inhibit lactation (milk production) after childbirth or to interrupt it. It is also used to treat disorders related to excessive prolactin secretion (e.g., irregular menstruation, lack of ovulation) and in the treatment of pituitary adenoma.

Form: tablets

ATC: G02CB03

Manufacturer: Pfizer BV

The medicine is used to inhibit lactation after childbirth or to stop milk secretion. It is also intended for the treatment of disorders related to excessive prolactin secretion (e.g., irregular periods, lack of ovulation) and for the treatment of pituitary adenoma.

Form: tablets

ATC: G02CB03

Manufacturer: Pfizer Europe MA EEIG